Abdominal and pelvic cancer
Conditions
Interventions
Trail Group (Using domestic accelerators for radiotherapy of patients with abdominal and pelvic tumors):NA
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients must sign the informed consent form for the study voluntarily and with the capacity for autonomous decision-making within 30 days before enrollment. (2) Pathologically confirmed primary tumors located in the abdominal and pelvic region, including cervical cancer, endometrial cancer, rectal cancer, etc. (3) For cervical cancer patients undergoing curative radiotherapy, FIGO stages I to IVA are eligible; for other tumor types, there is no restriction on the staging. (4) Patients must meet the indications for abdominal and pelvic external irradiation treatment. (5) Prior to enrollment, all required assessments and examinations necessary for pre-treatment must be completed. (6) Must be willing and able to undergo regular follow-up.
Exclusion criteria
Exclusion criteria: (1) Intended for abdominal and pelvic extraregional irradiation. (2) Intended for stereotactic radiotherapy (SRT) or stereotactic ablative radiotherapy (SABR) for abdominal and pelvic metastatic lesions. (3) Severe medical conditions that may significantly affect compliance with the clinical trial, such as unstable heart disease requiring treatment, kidney disease, chronic hepatitis, poorly controlled diabetes, and psychiatric disorders. (4) Other situations deemed unsuitable for participation in this clinical study by the research team.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| OS;LC; | — |
Countries
China
Contacts
Public ContactZhikai Liu
Peking Union Medical College Hospital
Outcome results
None listed